Sofosbuvir/velpatasvir
id:
sofosbuvir-velpatasvir-293-16010633
title:
Sofosbuvir/velpatasvir
text:
Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. It combines sofosbuvir and velpatasvir. It is more than 90% effective for hepatitis C genotypes one through six. It also works for hepatitis C in those who also have cirrhosis or HIV/AIDS. It is taken by mouth. In March 2020, sofosbuvir/velpatasvir was approved for use in the United States to treat hepatitis C virus (HCV) in children ages six
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Sofosbuvir/velpatasvir
date created:
date modified:
2024-04-07T05:20:17Z
main entity:
{"identifier":"Q25110523","url":"https://www.wikidata.org/entity/Q25110523"}
image:
fields total:
13
integrity:
14